Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German pharma rebates fund health insurer surplus, but drug spending rises again

This article was originally published in Scrip

Executive Summary

German health insurers enjoyed a €4 billion surplus in 2011, fuelled partly by a 4% drop in drug spending, which was in turn driven by increased mandatory rebates and a price freeze introduced in 2010. Although drug spending in Germany appears to be rising again, pharmaceutical companies will be calling for the government to reduce rebates to previous levels, says the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE).

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC016567

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel